Skip to main content
. 2016 Mar 18;7:347. doi: 10.3389/fmicb.2016.00347

Figure 4.

Figure 4

In-vitro antimicrobial activity of EA-PB-52 following disc diffusion method against (A) S. aureus MTCC 96 (B) C. albicans MTCC 227 (i) 10% DMSO (negative control), (ii) 20 μg/disc rifampicin (positive control), (iii) 30 μg/disc amphotericin B (positive control), (iv) 20 μg/disc EA-PB-52.